[HTML][HTML] The role of proteomics in biomarker development for improved patient diagnosis and clinical decision making in prostate cancer
Prostate Cancer (PCa) is the second most commonly diagnosed cancer in men worldwide.
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …
[HTML][HTML] The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer
CL Tonry, E Leacy, C Raso, SP Finn, J Armstrong… - Diagnostics, 2016 - ncbi.nlm.nih.gov
Abstract Prostate Cancer (PCa) is the second most commonly diagnosed cancer in men
worldwide. Although increased expression of prostate-specific antigen (PSA) is an effective …
worldwide. Although increased expression of prostate-specific antigen (PSA) is an effective …
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer
CL Tonry, E Leacy, C Raso, SP Finn… - Diagnostics (Basel …, 2016 - pubmed.ncbi.nlm.nih.gov
Prostate Cancer (PCa) is the second most commonly diagnosed cancer in men worldwide.
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer.
CL Tonry, E Leacy, C Raso, SP Finn… - Diagnostics (Basel …, 2016 - europepmc.org
Abstract Prostate Cancer (PCa) is the second most commonly diagnosed cancer in men
worldwide. Although increased expression of prostate-specific antigen (PSA) is an effective …
worldwide. Although increased expression of prostate-specific antigen (PSA) is an effective …
[PDF][PDF] The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer.
CL Tonry, E Leacy, C Raso, S Finn - academia.edu
Prostate Cancer (PCa) is the second most commonly diagnosed cancer in men worldwide.
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer.
CL Tonry, E Leacy, C Raso, SP Finn, J Armstrong… - lenus.ie
Prostate Cancer (PCa) is the second most commonly diagnosed cancer in men worldwide.
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer.
CL Tonry, E Leacy, C Raso, SP Finn… - Diagnostics (2075 …, 2016 - search.ebscohost.com
Abstract Prostate Cancer (PCa) is the second most commonly diagnosed cancer in men
worldwide. Although increased expression of prostate-specific antigen (PSA) is an effective …
worldwide. Although increased expression of prostate-specific antigen (PSA) is an effective …
[PDF][PDF] The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer
CL Tonry, E Leacy, C Raso, SP Finn, J Armstrong… - scienceopen.com
Prostate Cancer (PCa) is the second most commonly diagnosed cancer in men worldwide.
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …
[PDF][PDF] The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer
CL Tonry, E Leacy, C Raso, SP Finn, J Armstrong… - pdfs.semanticscholar.org
Prostate Cancer (PCa) is the second most commonly diagnosed cancer in men worldwide.
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …
[PDF][PDF] The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer
CL Tonry, E Leacy, C Raso, SP Finn, J Armstrong… - researchgate.net
Prostate Cancer (PCa) is the second most commonly diagnosed cancer in men worldwide.
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …
Although increased expression of prostate-specific antigen (PSA) is an effective indicator for …